首页 | 本学科首页   官方微博 | 高级检索  
     

组织选择性雌激素活性调节剂辅助钙剂治疗绝经后骨质疏松症
引用本文:王鑫,唐亮,何平. 组织选择性雌激素活性调节剂辅助钙剂治疗绝经后骨质疏松症[J]. 中国妇幼保健, 2008, 23(11): 1535-1536
作者姓名:王鑫  唐亮  何平
作者单位:1. 中国医科大学附属盛京医院干诊科,辽宁,沈阳,110004
2. 沈阳医学院附属奉天医院循环科
摘    要:目的:观察绝经后妇女口服组织选择性雌激素活性调节剂加钙剂治疗骨质疏松症的效果。方法:将90例绝经后骨质疏松症患者随机分为2组,治疗组口服组织选择性雌激素活性调节剂加钙剂,对照组口服钙剂,追踪观察6个月,观察临床症状及骨密度的变化情况。结果:治疗组总有效率93%,明显高于对照组的73%(P<0·05)。治疗组治疗后的骨密度显著增加(P<0·05),与对照组同期比较差异显著(P<0·05)。结论:口服组织选择性雌激素活性调节剂加钙剂治疗绝经后骨质疏松症优于单用钙剂治疗。

关 键 词:组织选择性雌激素活性调节剂  钙剂  绝经  骨质疏松症
文章编号:1001-4411(2008)11-1535-02

The effects of selective tissue estrogen activity regulators combined with calcium on postmenopausal osteoporosis
WANG Xin,TANG Liang,HE Ping. The effects of selective tissue estrogen activity regulators combined with calcium on postmenopausal osteoporosis[J]. Maternal and Child Health Care of China, 2008, 23(11): 1535-1536
Authors:WANG Xin  TANG Liang  HE Ping
Abstract:Objective:To observe the effects of selective tissue estrogen activity regulators combined with calcium on postmenopausal osteoporosis.Methods:Ninety postmenopausal women were randomly divided into experiment and control groups.Experiment group was given selective tissue estrogen activity regulators and calcium for 6 months.Control group was given calcium only for 6 months.The changes of clinical symptoms and bone mineral density (BMD) were observed.Results:The total effective rate of the experiment group (93%) was significantly higher than that of the control group (73%)(P<0.05).BMD was increased significantly in the experiment group compared with the control group (P<0.05).Conclusion:Selective tissue estrogen activity regulators combined with calcium may improve the clinical symptoms and increase the BMD of postmenopausal osteoporotic women more effectively than calcium only.
Keywords:Selective tissue estrogen activity regulators  Calcium  Menopause  Osteoporosis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号